CXHB1400005 | 甲苯磺酸多纳非尼片 | donafenib tosylate | Tablet | Chemical Drugs | Supplementary Application | 2014-03-11 | 苏州泽璟生物制药有限公司 | Suzhou Zelgen Biopharmaceuticals Co Ltd | Certificate Issued | 2014-12-01 | view |
CXHB1500034 | 甲苯磺酸多纳非尼 | donafenib tosylate | Active ingredient | Chemical Drugs | Supplementary Application | 2015-04-21 | 苏州泽璟生物制药有限公司 | Suzhou Zelgen Biopharmaceuticals Co Ltd | Certificate Issued | 2015-10-29 | view |
CXHB1500035 | 甲苯磺酸多纳非尼片 | donafenib tosylate | Tablet | Chemical Drugs | Supplementary Application | 2015-04-21 | 苏州泽璟生物制药有限公司 | Suzhou Zelgen Biopharmaceuticals Co Ltd | Certificate Issued | 2015-10-29 | view |
CXHB1500036 | 甲苯磺酸多纳非尼片 | donafenib tosylate | Tablet | Chemical Drugs | Supplementary Application | 2015-04-21 | 苏州泽璟生物制药有限公司 | Suzhou Zelgen Biopharmaceuticals Co Ltd | Certificate Issued | 2015-10-20 | view |
CXHB1500037 | 甲苯磺酸多纳非尼片 | donafenib tosylate | Tablet | Chemical Drugs | Supplementary Application | 2015-04-21 | 苏州泽璟生物制药有限公司 | Suzhou Zelgen Biopharmaceuticals Co Ltd | Certificate Issued | 2015-10-20 | view |
CXHB1700111 | 甲苯磺酸多纳非尼 | donafenib tosylate | Active ingredient | Chemical Drugs | Supplementary Application | 2018-01-03 | 神隆医药(常熟)有限公司 | Shenlong Medicine (Changshu) Co Ltd | In Review | 2018-01-02 | view |
CXHL1100606 | 甲苯磺酸多纳非尼 | donafenib tosylate | Active ingredient | Chemical Drugs(1.1) | New Drug Application | 2011-12-28 | 苏州泽璟生物制药有限公司 | Suzhou Zelgen Biopharmaceuticals Co Ltd | Certificate Issued | 2012-11-29 | view |
CXHL1100607 | 甲苯磺酸多纳非尼片 | donafenib tosylate | Tablet | Chemical Drugs(1.1) | New Drug Application | 2011-12-28 | 苏州泽璟生物制药有限公司 | Suzhou Zelgen Biopharmaceuticals Co Ltd | Certificate Issued | 2012-11-29 | view |
CXHL1100608 | 甲苯磺酸多纳非尼片 | donafenib tosylate | Tablet | Chemical Drugs(1.1) | New Drug Application | 2011-12-28 | 苏州泽璟生物制药有限公司 | Suzhou Zelgen Biopharmaceuticals Co Ltd | Certificate Issued | 2012-11-29 | view |
CXHL1900249 | 甲苯磺酸多纳非尼片 | donafenib tosylate | Tablet | Chemical Drugs(1) | New Drug Application | 2019-08-22 | 苏州泽璟生物制药股份有限公司 | Suzhou Zelgen Biopharmaceuticals Co Ltd | In Review | 2019-08-20 | view |
CXHL1900444 | 甲苯磺酸多纳非尼片 | donafenib tosylate | Tablet | Chemical Drugs(1) | New Drug Application | 2020-01-01 | 苏州泽璟生物制药股份有限公司 | Suzhou Zelgen Biopharmaceuticals Co Ltd | In Review | 2019-12-31 | view |
CXHL1900445 | 甲苯磺酸多纳非尼片 | donafenib tosylate | Tablet | Chemical Drugs(1) | New Drug Application | 2020-01-01 | 苏州泽璟生物制药股份有限公司 | Suzhou Zelgen Biopharmaceuticals Co Ltd | In Review | 2019-12-31 | view |
CXHL2000055 | 甲苯磺酸多纳非尼片 | donafenib tosylate | Tablet | Chemical Drugs(1) | New Drug Application | 2020-02-25 | 苏州泽璟生物制药股份有限公司 | Suzhou Zelgen Biopharmaceuticals Co Ltd | In Review | 2020-02-24 | view |
CXHL2000165 | 甲苯磺酸多纳非尼片 | donafenib tosylate | Tablet | Chemical Drugs(1) | New Drug Application | 2020-04-27 | 苏州泽璟生物制药股份有限公司 | Suzhou Zelgen Biopharmaceuticals Co Ltd | In Review | 2020-04-26 | view |
CXHL2000166 | 甲苯磺酸多纳非尼片 | donafenib tosylate | Tablet | Chemical Drugs(1) | New Drug Application | 2020-04-27 | 苏州泽璟生物制药股份有限公司 | Suzhou Zelgen Biopharmaceuticals Co Ltd | In Review | 2020-04-26 | view |
CXHL2000203 | 甲苯磺酸多纳非尼片 | donafenib tosylate | Tablet | Chemical Drugs(1) | New Drug Application | 2020-05-09 | 苏州泽璟生物制药股份有限公司 | Suzhou Zelgen Biopharmaceuticals Co Ltd | In Review | 2020-05-08 | view |
CXHL2000204 | 甲苯磺酸多纳非尼片 | donafenib tosylate | Tablet | Chemical Drugs(1) | New Drug Application | 2020-05-09 | 苏州泽璟生物制药股份有限公司 | Suzhou Zelgen Biopharmaceuticals Co Ltd | In Review | 2020-05-08 | view |
CXHL2000238 | 甲苯磺酸多纳非尼片 | donafenib tosylate | Tablet | Chemical Drugs(1) | New Drug Application | 2020-06-03 | 苏州泽璟生物制药股份有限公司 | Suzhou Zelgen Biopharmaceuticals Co Ltd | In Review | 2020-06-02 | view |
CXHL2000239 | 甲苯磺酸多纳非尼片 | donafenib tosylate | Tablet | Chemical Drugs(1) | New Drug Application | 2020-06-03 | 苏州泽璟生物制药股份有限公司 | Suzhou Zelgen Biopharmaceuticals Co Ltd | In Review | 2020-06-02 | view |
CXHS2000010 | 甲苯磺酸多纳非尼片 | donafenib tosylate | Tablet | Chemical Drugs(1) | New Drug Application | 2020-05-15 | 苏州泽璟生物制药股份有限公司 | Suzhou Zelgen Biopharmaceuticals Co Ltd | In Review | 2020-05-14 | view |